Evidence map›Paper›PMID 41981467›Full record

ArticleBMC microbiology2026

Anti-staphylococcal activity of soil-derived Penicillium citrinum extract.

Yousrah Yasser M Dusuki, Michael G Shehat, Amal M Khalil, Gehan M Aboelela, Alaa A Y Abouelfetouh

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yousrah Yasser M DusukiDepartment of Microbiology and Immunology, Faculty of Pharmacy, Alamein International University, Alamein, Egypt.
Michael G ShehatDepartment of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Michael.Shehat@alexu.edu.eg.
Amal M KhalilDepartment of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
Gehan M AboelelaMicrobiology lab, Marine Environment Division, National Institute of Oceanography and Fisheries (NIOF), Alexandria, Egypt.
Alaa A Y AbouelfetouhDepartment of Microbiology and Immunology, Faculty of Pharmacy, Alamein International University, Alamein, Egypt. Alaa.abouelfetouh@alexu.edu.eg.

Funding

Deutsche Forschungsgemeinschaft ZI665/3-2.
6 · The paper itself

Abstract

backgroundThe increasing prevalence of methicillin resistant S. aureus (MRSA) led to higher morbidity, mortality, and treatment costs. The escalating antibiotic resistance levels and the stagnation in antibiotic discovery highlight the need for novel therapeutic alternatives. Soil fungi are a source of antimicrobial agents, given their capacity to produce diverse bioactive metabolites. Soil fungi from Alexandria, Egypt was investigated for extracts with anti-staphylococcal potential.

methodsSoil samples were collected and fungal isolates were obtained on potato dextrose agar (PDA). Isolates were screened for antibacterial activity using agar well diffusion technique against standard bacterial strains. Minimum inhibitory concentration (MIC) of most active fungal extract was determined against S. aureus, including MRSA. Checkerboard assay was performed to assess the combination with commonly used antibiotics and MTT assay was used to evaluate the extract's cytotoxicity. Major active metabolites were characterized by gas chromatography-mass spectrometry (GC-MS) and a growth curve analysis was subsequently conducted to evaluate the antibacterial/growth inhibition activity of the most abundant metabolite.

resultsTwenty-three fungal isolates were obtained, Penicillium citrinum extract showed the strongest anti-staphylococcal activity. Plackett-Burman analysis was used to optimize fermentation conditions to enhance anti-staphylococcal activity. The MIC of the butanolic extract ranged between 500 and 1000 µg/mL against commensal, clinical and standard S. aureus. P. citrinum extract combination with gentamicin was synergistic against all clinical MRSA isolates and its combination with ciprofloxacin was synergistic against 37.5% of the isolates. Cytotoxicity on the human skin fibroblast cell line confirmed the safety of the extract at the concentrations used in the synergistic combinations. GC-MS analysis revealed the most abundant bioactive metabolites to be dibutyl phthalate (10.58%), tridecane (7.58%) and hexadecane (7.42%). Growth curve analysis of a representative clinical MRSA isolate in the presence of dibutyl phthalate showed its growth inhibition properties but with no enhancement of the gentamicin efficacy highlighting the importance of the extract as a whole.

conclusionThis study highlights Penicillium citrinum as a promising source for safe and effective antimicrobial agents, particularly as an adjunct to antibiotics against resistant staphylococcal infections.

Indexed as

Anti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusPenicilliumSoil MicrobiologyCell LineEgyptGas Chromatography-Mass SpectrometryHumansMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsAntibacterialCytotoxicityGC-MSMRSAPlackett-Burman designSoil fungi

Identifiers

PMID41981467
PMCPMC13085357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.